HYALURONIC ACID WITH POLYETHYLENE GLYCOL 400 WITH PROPYLENE GLYCOL WITH HYDROXYPROPYL GUAR

Information current as at: 1 June 2025

The pharmaceutical company has advised that it is not proceeding in the PBS listing process at this time. The process for listing this medicine has ceased.


Legend: Completed N In progress Not applicable N Yet to commence

Submission Details

Brand name:
  • Systane® Hydration
Pharmaceutical company:
Alcon Laboratories (Australia) Pty Ltd
Condition/indication:
(therapeutic use)
  • Severe dry eye syndrome
PBAC Submission type:
New PBS listing (–)
Comment:
--

Progress Details

Submission received for:
May 2023 PBAC meeting
Opportunity for consumer comment:
Open 23/11/2022 and close 25/01/2023 (see PBS Website)
PBAC meeting:
Held on 05/05/2023
PBAC outcome published:
Recommended (see PBAC Outcomes)
Notice of intent submitted:
30/06/2023
Lodgement of required documentation:
Not applicable
Agreement to listing arrangements:
Not applicable
Government processes:
Not applicable
Medicine listed on the PBS:
Not applicable

Case ID: a735

Page last updated: 02 May 2024

v.9.18